These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9617206)

  • 21. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency.
    Roggia C; Tamone C; Cenci S; Pacifici R; Isaia GC
    Minerva Med; 2004 Apr; 95(2):125-32. PubMed ID: 15272247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired cutaneous wound healing with excess granulation tissue formation in TNFalpha-null mice.
    Shinozaki M; Okada Y; Kitano A; Ikeda K; Saika S; Shinozaki M
    Arch Dermatol Res; 2009 Aug; 301(7):531-7. PubMed ID: 19543902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal cloning by nuclear transfer: state-of-the-art and future perspectives.
    Dinnyes A; Szmolenszky A
    Acta Biochim Pol; 2005; 52(3):585-8. PubMed ID: 16175234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.
    Sivinski CL; Kohlgraf KG; VanLith ML; Morikane K; Tempero RM; Hollingsworth MA
    Cancer Immunol Immunother; 2002 Aug; 51(6):327-40. PubMed ID: 12111121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wound healing studies in transgenic and knockout mice. A review.
    Grose R; Werner S
    Methods Mol Med; 2003; 78():191-216. PubMed ID: 12825272
    [No Abstract]   [Full Text] [Related]  

  • 26. Tissue-specific transgenic, conditional knockout and knock-in mice of genes in the canonical Wnt signaling pathway.
    Aoki K; Taketo MM
    Methods Mol Biol; 2008; 468():307-31. PubMed ID: 19099265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
    Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
    J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.
    Capocasale RJ; Makropoulos DA; Achuthanandam R; Stowell N; Quinn J; Rafferty PA; O'Brien J; Emmell E; Bugelski PJ
    Cytometry A; 2008 Feb; 73(2):148-59. PubMed ID: 18205195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous and engineered mutant mice as models for experimental and comparative pathology: history, comparison, and developmental technology.
    Roths JB; Foxworth WB; McArthur MJ; Montgomery CA; Kier AB
    Lab Anim Sci; 1999 Feb; 49(1):12-34. PubMed ID: 10090091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of TIMP-1 under the MMP-9 promoter interferes with wound healing in transgenic mice.
    Salonurmi T; Parikka M; Kontusaari S; Pirilä E; Munaut C; Salo T; Tryggvason K
    Cell Tissue Res; 2004 Jan; 315(1):27-37. PubMed ID: 14569458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing.
    Lehmann W; Edgar CM; Wang K; Cho TJ; Barnes GL; Kakar S; Graves DT; Rueger JM; Gerstenfeld LC; Einhorn TA
    Bone; 2005 Feb; 36(2):300-10. PubMed ID: 15780956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic mice: an irreplaceable tool for the study of mammalian development and biology.
    Babinet C
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S88-94. PubMed ID: 11065337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic mice.
    Hickman-Davis JM; Davis IC
    Paediatr Respir Rev; 2006 Mar; 7(1):49-53. PubMed ID: 16473817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
    Mauvais-Jarvis F; Kahn CR
    Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genes and physiology: molecular physiology in genetically engineered animals.
    Chien KR
    J Clin Invest; 1996 Feb; 97(4):901-9. PubMed ID: 8613542
    [No Abstract]   [Full Text] [Related]  

  • 36. Transgenic mice in cancer research.
    Jenkins NA; Copeland NG
    Important Adv Oncol; 1989; ():61-77. PubMed ID: 2651297
    [No Abstract]   [Full Text] [Related]  

  • 37. [Transgenic mice, basic research and source of wishes].
    Loerum OD
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):171. PubMed ID: 8430393
    [No Abstract]   [Full Text] [Related]  

  • 38. Autopsy and histological analysis of the transgenic mouse.
    Gijbels MJ; de Winther MP
    Methods Mol Biol; 2011; 693():75-87. PubMed ID: 21080275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically engineered mice and their use in aging research.
    Andersen JK
    Mol Biotechnol; 2001 Sep; 19(1):45-57. PubMed ID: 11697220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine mentors: transgenic and knockout models of surgical disease.
    Arbeit JM; Hirose R
    Ann Surg; 1999 Jan; 229(1):21-40. PubMed ID: 9923797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.